Turmeric is one the most thoroughly researched plants in existence today. Its medicinal properties and components (primarily curcumin) have been the subject of over 5600 peer-reviewed and published biomedical studies. In fact, our five-year long research project on this sacred planthas revealed over 600 potential preventive and therapeutic applications, as well as 175 distinct beneficial physiological effects. This entire database of 1,585 ncbi-hyperlinked turmeric abstracts can be downloaded as a PDF at our Downloadable Turmeric Document page, and acquired either as a retail item or with 200 GMI-tokens, for those of you who are already are members and receive them automatically each month.
Given the sheer density of research performed on this remarkable spice, it is no wonder that a growing number of studies have concluded that it compares favorably to a variety of conventional medications, including:
- Lipitor/Atorvastatin(cholesterol medication): A 2008 study published in the journal Drugs in R & D found that a standardized preparation of curcuminoids from Turmeric compared favorably to the drug atorvastatin (trade name Lipitor) on endothelial dysfunction, the underlying pathology of the blood vessels that drives atherosclerosis, in association with reductions in inflammation and oxidative stress in type 2 diabetic patients. [i] [For addition curcumin and 'high cholesterol' research – 8 abstracts]
Federal sequestration measures that came into effect on April 1 are making it impossible for many cancer clinics across the country to administer conventional care to patients, and particularly to those on Medicare. Consequently, thousands of cancer patients with taxpayer-funded insurance coverage are being turned away, according to reports, as clinics simply do not have the capacity nor the funding to administer expensive pharmaceutical-based treatments such as chemotherapy.
According to the Washington Post, many cancer clinics are having to turn away patients without adequate coverage, or else face potential closure of their practices. Since many of the latest cancer drugs now cost upwards of $35,000 or more per year, it is grossly unsustainable to deliver such treatments to patients without adequate insurance coverage — doing so would spell financial suicide for even the most successful and well-funded cancer clinics.
“If we treated the patients receiving the most expensive drugs, we’d be out of business in six months to a year,” said Jeff Vacirca, chief executive of North Shore Hematology Oncology Associates in New York, to the Washington Post. “The drugs we’re going to lose money on we’re not going to administer right now.”
Natural News ~ Ever since chemotherapy was introduced into the practice of western medicine, doctors and oncologists have been trying to answer this nagging question: Why does chemotherapy seem to work at first, but then cancer tumors cells grow back even more aggressively while the body becomes resistant to chemotherapy?
It turns out that chemotherapy damages healthy cells, causing them to secrete a protein that accelerates the growth of cancer tumors. (http://ca.news.yahoo.com/chemotherapy-backfire-boost-cancer-growth-st…)
This protein, dubbed “WNT16B,” is taken up by nearby cancer cells, causing them to “grow, invade, and importantly, resist subsequent therapy,” said Peter Nelson of the Fred Hutchinson Cancer Research Center in Seattle. He’s the co-author of the study that documented this phenomenon, published in Nature Medicine.
This protein, it turns out, explains why cancer tumors grow more aggressively following chemotherapy treatments. In essence, chemotherapy turns healthy cells into WNT16B factories which churn out this “activator” chemical that accelerates cancer tumor growth.
The findings of the study were confirmed with prostate cancer, breast cancer and ovarian cancer tumors. This discovery that chemotherapy backfires by accelerating cancer tumor growth is being characterized as “completely unexpected” by scientists.
The chemotherapy fraud exposed
Ginger, a cousin spice of super anti-cancer substance turmeric, is known for its ability to shrink tumors. Astoundingly, it is even more effective than many cancer drugs, which have been shown to be completely ineffective and actually accelerate the death of cancer patients. Commonly consumed across the world in small doses among food and beverage products, the medicinal properties of ginger far surpass even advanced pharmaceutical inventions.
The subject of one study based out of Georgia State University, whole ginger extract was revealed to shrink prostate tumor size by a whopping 56% in mice. The anticancer properties were observed in addition to ginger’s role in reducing inflammation as well as being a rich source of life-enhancing antioxidants. But what about cancer drugs? Could this simple spice really topple the advanced pharmaceuticals that are often touted as the ‘only option’ for cancer patients by medical doctors?